Grandfield & Dodd LLC Cuts Stock Position in Intuitive Surgical, Inc. $ISRG

Grandfield & Dodd LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 3,756 shares of the medical equipment provider’s stock after selling 450 shares during the quarter. Grandfield & Dodd LLC’s holdings in Intuitive Surgical were worth $2,041,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after purchasing an additional 453,335 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Intuitive Surgical by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock worth $4,429,590,000 after buying an additional 109,904 shares during the last quarter. Invesco Ltd. lifted its position in shares of Intuitive Surgical by 1.7% in the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after acquiring an additional 71,794 shares in the last quarter. Northern Trust Corp boosted its stake in shares of Intuitive Surgical by 0.3% in the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after acquiring an additional 11,988 shares during the last quarter. Finally, Wellington Management Group LLP increased its position in shares of Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Brian Edward Miller sold 3,500 shares of the firm’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president directly owned 5,758 shares in the company, valued at $3,310,850. This trade represents a 37.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This represents a 9.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 116,164 shares of company stock worth $61,916,172 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 1.2%

ISRG stock opened at $565.51 on Friday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock has a market cap of $202.72 billion, a price-to-earnings ratio of 74.80, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. The business has a fifty day moving average of $480.86 and a two-hundred day moving average of $502.93.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 EPS. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on ISRG shares. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, October 31st. Finally, Robert W. Baird set a $655.00 price objective on Intuitive Surgical in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.